Livforsakringsbolaget Skandia Omsesidigt Raises Stake in HCA Healthcare, Inc. $HCA

Key Points

• Livforsakringsbolaget Skandia Omsesidigt significantly increased its stake in HCA Healthcare by 667.5% during Q2, now owning approximately 132,000 shares valued at about $50.6 million.
• HCA Healthcare reported earnings of $6.84 per share, exceeding expectations, with total revenue of $18.61 billion, marking a 6.4% year-over-year increase.
• The company declared a quarterly dividend of $0.72 per share, set to be paid on September 30th, reflecting an annualized yield of 0.7%.

Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 667.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 131,999 shares of the company's stock after acquiring an additional 114,800 shares during the quarter. HCA Healthcare makes up approximately 0.1% of Livforsakringsbolaget Skandia Omsesidigt's portfolio, making the stock its 14th biggest position. Livforsakringsbolaget Skandia Omsesidigt owned 0.05% of HCA Healthcare worth $50,569,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock worth $8,796,000 after acquiring an additional 2,698 shares during the period. Brown Advisory Inc. lifted its position in shares of HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after purchasing an additional 1,622 shares during the period. Farther Finance Advisors LLC lifted its holdings in HCA Healthcare by 26.9% in the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after buying an additional 242 shares during the period. Oppenheimer Asset Management Inc. lifted its stake in shares of HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock valued at $1,491,000 after purchasing an additional 105 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after purchasing an additional 737 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA traded up $1.00 on Friday, reaching $402.06. 4,308,470 shares of the company's stock traded hands, compared to its average volume of 1,077,287. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a market cap of $94.08 billion, a PE ratio of 16.90, a PEG ratio of 1.26 and a beta of 1.41. The stock's 50 day simple moving average is $385.21 and its two-hundred day simple moving average is $365.77. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the firm posted $5.50 EPS. The business's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

Analysts Set New Price Targets

Several brokerages have issued reports on HCA. Royal Bank Of Canada dropped their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Barclays upped their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an "overweight" rating in a report on Thursday. Morgan Stanley dropped their price target on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Finally, Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $407.75.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.